Dromex Internacional

[Not Yet Scheduled]
Dromex International specializes in product development for the pharmaceutical industry.
We provide Active Pharmaceutical Ingredients with biological origin as well as finished pharmaceutical products. Right now, we are focused on the inmune response to recombinant proteins. For this we have developed 2 different detection kits: Anti Eritropoeitin Antibody and Anti Etanercept Antibody.
They have two advantages: These kits include a procedure to rule out false positives and they are produced with the client´s protein, which lets them establish authority approved pharmacovigilance protocols.
Ticker:
Pharmaceutical Developments
Exchange:
60$/u$s
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Argentina
Year Founded:
2003
Main Therapeutic Focus:
Lead Product in Development:
Antibodys Against Recombinant Proteins
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
10
Speaker
photo
Biotech Consultant
Dromex Internacional